Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Liver Stiffness to Assess Central Venous Pressure in HF
Author(s): Nicolas Girerd Added: 8 months ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive… View more

Cardiovascular Renal Metabolic

Heart Failure
Arterial Hypertension: Highlights from the European Society of Cardiology 2025 Congress
Author(s): Maria Lorenza Muiesan , Matteo Lemoli Added: 2 months ago

Prevention & Chronic Conditions
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 7 months ago

Guidelines & Statements
Viewpoint on Arterial Hypertension
Author(s): Maria Lorenza Muiesan Added: 10 months ago

Prevention & Chronic Conditions
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 year ago

Vascular Disease and Surgery
AFSymposium 24: Long-Term Effects of PFA on Coronary Arteries
Author(s): Yury Malyshev Added: 1 year ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take… View more

Electrophysiology & Arrhythmia
Management of Left Main Coronary Artery Disease
Author(s): Gabriel Torres-Ruiz , Nuria Mallofré-Vila , Paola Rojas-Flores , et al Added: 2 years ago

Intervention

Prevention & Chronic Conditions
ESC HF 25: The FIVE-STAR Trial
Author(s): Added: 8 months ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2… View more

Cardiovascular Renal Metabolic
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 4 months ago

Intervention

Prevention & Chronic Conditions
Dual-pathway Inhibition versus Aspirin Monotherapy
Author(s): Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al Added: 1 year ago

Anticoagulation

Prevention & Chronic Conditions